Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
PLOS ONE, 2023Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
Siegbahn A., Eriksson N., Assarsson E. et al.
Olink Focus
Journal of Experimental & Clinical Cancer Research, 2023Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Wimmer K., Sachet M., Ramos C. et al.
Olink Target 96
International Journal of Hygiene and Environmental Health, 2023Joint association of air pollution exposure and inflammation-related proteins in relation to infant lung function
He S., Lundberg B., Hallberg J. et al.
American Journal of Respiratory and Critical Care Medicine, 2023Host Response Changes and Their Association with Mortality in COVID-19 Patients with Lymphopenia
Michels E., Appelman B., de Brabander J. et al.
Olink Explore 3072/384
Clinical and Translational Medicine, 2023Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Meng H., Sengupta A., Ricciotti E. et al.
European Heart Journal, 2023Autoantibodies against the chemokine receptor 3 predict cardiovascular risk
Müller F., Aherrahrou Z., Grasshoff H. et al.
ESC Heart Failure, 2023Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial
Santos‐Ferreira D., Diaz S., Ferreira J. et al.
BMC Cancer, 2023Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study
Hau S., Svensson M., Petersson A. et al.
iScience, 2023TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
Steitz A., Schröder C., Knuth I. et al.
Journal of Cardiac Failure, 2023Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial
Razaghizad A., Aziz H., Zhang G. et al.
Journal of the American College of Cardiology, 2023Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
Mazidi M., Wright N., Yao P. et al.
Journal of the American College of Cardiology, 2023Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure
Ouwerkerk W., Belo Pereira J., Maasland T. et al.
Nature Genetics, 2023Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis
Stacey S., Zink F., Halldorsson G. et al.
Translational Vision Science & Technology, 2023Correlation of Aqueous, Vitreous, and Serum Protein Levels in Patients With Retinal Diseases
Wilson S., Siebourg-Polster J., Titz B. et al.
Brain Communications, 2023Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis
Zhu W., Chen C., Zhang L. et al.
Communications Biology, 2023Identification of circulating proteins associated with general cognitive function among middle-aged and older adults
Tin A., Fohner A., Yang Q. et al.
BMC Medicine, 2023Associations of ultra-processed food consumption, circulating protein biomarkers, and risk of cardiovascular disease
Li H., Wang Y., Sonestedt E. et al.
Kidney International Reports, 2023Proteome-Wide Changes in Blood Biomarkers During Hemodialysis
Lanktree M., Collister D., Pigyere M. et al.
Kidney Medicine, 2023Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study
Hayward S., Chesnaye N., Hole B. et al.
Cell Reports Medicine, 2023Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
Jia X., Song E., Liu Y. et al.
3247 publications
Items per page
1701-1720 of 3247 publications